40.93 F
Port Huron
Latest

The Prophecy of Port Huron

Hope in Him – Justin Fahrenbrunch, President of Kingdom Fire Ministries

A Higher Outlook – KAYE E. BARKER

The Extra Mile

The Power of God’s Healing – Jill Janiec

Where is the Church – Roy Roy

Hope in Him – Patrick Patterson, Executive Director of BWROC

Joshua Jones – Blue Water Christian Church

Foster Care Abuse Cover-up – Isaac Thomas

It’s Just Not So

FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo
FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo
Health

Bayer acquires rights in Puhe BioPharma cancer drug candidate

by Reuters

FRANKFURT (Reuters) -Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with China’s Puhe BioPharma.

Bayer, which did not disclose financial terms, said it had enrolled the first patient to test the drug, a PRMT5 inhibitor that selectively targets MTAP-deleted tumors, in the first phase of clinical trials.

(Reporting by Ludwig Burger, editing by Rachel More)

Image

Reuters
Information you can trust. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. (c) 2025 Thomson Reuters

Related posts

Study strengthens link between maternal diabetes and autism

Reuters

Britain to invest up to $767 million in new health data research

Reuters

Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil

Reuters

US health insurers jump as 2026 Medicare payment rates exceed expectations

Reuters

UN food agency WFP: US funding cuts could be 'death sentence' for millions

Reuters

New 'surprising' case of mpox variant clade lb detected in England

Reuters

UK's Assura gets deadline extension for potential PHP deal

Reuters

Rhythm Pharma's drug for rare obesity meets late-stage trial goal

Reuters

China's Duality Biotherapeutics tests market appetite with up to $200 million Hong Kong IPO

Reuters

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.

@2025